Peptides containing antigenic and cationic domains have enhanced, multivalent immunogenicity when bound to DNA vaccines.
We explored strategies to codeliver DNA- and peptide-based vaccines in a way that enhances the immunogenicity of both components of the combination vaccine for T cells. Specific CD8(+) T cell responses to an antigenic peptide are primed when the peptide is fused to a cationic peptide domain that is bound to plasmid DNA or oligonucleotides (ODN; with or without CpG motifs). Plasmid DNA mixed with antigenic/cationic peptides or histones forms large complexes with different biological properties depending on the molar ratios of peptide/protein and polynucleotide. Complexes containing high (but not low) molar ratios of cationic peptide to DNA facilitate transfection (DNA uptake and expression of the plasmid-encoded product) of cells. In contrast, complexes containing low (but not high) molar ratios of cationic peptide to DNA prime potent multispecific T cell responses after a single intramuscular injection of the complexes. The general validity of this observation was confirmed mixing different antigenic/cationic peptides with different DNA vaccines. In these vaccine formulations, multispecific CD8(+) T cell responses specific for epitopes of the peptide- as well as the DNA-based vaccine were efficiently coprimed, together with humoral antibody responses to conformational determinants of large viral antigens encoded by the DNA vaccine. The data indicate that mixtures of DNA vaccines with antigenic, cationic peptides are immunogenic vaccine formulations particularly suited for the induction of multispecific T cell responses.
Riedl
Petra
P
Institute for Medical Microbiology and Immunology, University of Ulm, Albert Einstein Allee 11, 89081, Ulm, Germany.
Reimann
Jörg
J
Schirmbeck
Reinhold
R
D000595:Amino Acid Sequence; D000818:Animals; D000906:Antibodies; D000941:Antigens / Q000737:chemistry / Q000276:immunology; D023181:Antimicrobial Cationic Peptides / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D015704:CD4 Antigens / Q000737:chemistry / Q000276:immunology / Q000378:metabolism; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology* / Q000378:metabolism; D002460:Cell Line; D005260:Female; D015696:Gene Products, tat / Q000737:chemistry / Q000276:immunology / Q000378:metabolism; D049452:Green Fluorescent Proteins; D006801:Humans; D007114:Immunization; D008164:Luminescent Proteins / Q000032:analysis; D008285:Major Histocompatibility Complex / Q000235:genetics / Q000276:immunology; D051379:Mice; D008815:Mice, Inbred Strains; D008969:Molecular Sequence Data; D010957:Plasmids / Q000235:genetics / Q000276:immunology / Q000378:metabolism; D019444:Vaccines, DNA / Q000737:chemistry / Q000276:immunology*
D000906:Antibodies; D000941:Antigens; D023181:Antimicrobial Cationic Peptides; D015704:CD4 Antigens; D015696:Gene Products, tat; D008164:Luminescent Proteins; D019444:Vaccines, DNA; D049452:Green Fluorescent Proteins